Latest filing published 22 Dec 2015 for BIOSPECIFICS TECHNOLOGIES CORP, €110k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jeffrey Kenneth Vogel: trading record in brief
Jeffrey Kenneth Vogel appears in our data through filings on Biospecifics Technologies Corp shares, published by SEC (Form 4). We count 182 filings; the first trade dates from 30 July 1991 and the latest from 25 November 2015.
On the open market, the record shows 137 purchases worth €2.8M and 45 sales worth €4.5M. Taken together, the sales exceed the purchases by €1.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2015 alone, the filings show 7 purchases and 13 sales.
A typical purchase (the median) is worth €2,547.
On 22 December 2015 came the latest disclosure, an open-market sale for €110k in Biospecifics Technologies Corp. The last insider purchase was made public on 22 December 2015, 3,974 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey Kenneth Vogel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$60.52Common StockSEC:0001019056-15-000962:0
- 5,000 shares@ US$60.70Common StockSEC:0001019056-15-000962:1
- 1,196 shares@ US$63.00Common StockSEC:0001019056-15-000962:2
- 3,000 shares@ US$62.00Common StockSEC:0001019056-15-000962:3
- 4,500 shares@ US$49.62Common StockSEC:0001019056-15-000962:4Canonical exit: 16 Feb 2016 (T+90)
- 1,900 shares@ US$48.26Common StockSEC:0001019056-15-000962:5Canonical exit: 17 Feb 2016 (T+90)
- 100 shares@ US$48.10Common StockSEC:0001019056-15-000962:6Canonical exit: 17 Feb 2016 (T+90)
- 974 shares@ US$48.47Common StockSEC:0001019056-15-000962:7Canonical exit: 23 Feb 2016 (T+90)
- 2,000 shares@ US$48.20Common StockSEC:0001019056-15-000962:8Canonical exit: 23 Feb 2016 (T+90)
- 1,026 shares@ US$48.24Common StockSEC:0001019056-15-000962:9Canonical exit: 23 Feb 2016 (T+90)
- 696 shares@ US$47.83Common StockSEC:0001019056-15-000962:10Canonical exit: 23 Feb 2016 (T+90)
- 2,785 shares@ US$28.85Common StockSEC:0001019056-15-000525:0
- 2,518 shares@ US$27.05Common StockSEC:0001019056-15-000525:1
- 4,010 shares@ US$39.15Common StockSEC:0001019056-15-000525:2
- 4,761 shares@ US$38.90Common StockSEC:0001019056-15-000525:3
- 2,000 shares@ US$39.15Common StockSEC:0001019056-15-000525:4
- 1,100 shares@ US$39.00Common StockSEC:0001019056-15-000525:5
- 2,000 shares@ US$39.25Common StockSEC:0001019056-15-000525:6
- 4,400 shares@ US$39.70Common StockSEC:0001019056-15-000525:7
- 2,500 shares@ US$39.69Common StockSEC:0001019056-15-000525:8
- 1,857 shares@ US$27.92Common StockSEC:0001019056-14-001080:0
- 98 shares@ US$27.85Common StockSEC:0001019056-14-001080:1
- 600 shares@ US$27.90Common StockSEC:0001019056-14-001080:2
- 9,400 shares@ US$27.75Common StockSEC:0001019056-14-001080:3
- 2,500 shares@ US$27.51Common StockSEC:0001019056-14-001080:4
25 of 182 declarations